Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.56 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.56 |
| ▸ | BACE1 | P56817 | 1/20 | 0.40 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.40 |
| ▸ | ACHE | P22303 | 2/20 | 0.39 |
| ▸ | ABL1 | P00519 | 1/20 | 0.39 |
| ▸ | AHR | P35869 | 2/20 | 0.38 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | CASP3 | P42574 | 1/20 | 0.36 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.36 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.36 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.36 |
| ▸ | SLC6A4 | P31645 | 4/20 | 0.36 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.36 |
| ▸ | HTR2A | P28223 | 1/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.35 |
| ▸ | CA3 | P07451 | 1/20 | 0.33 |
| ▸ | CA6 | P23280 | 1/20 | 0.33 |
| ▸ | CA5A | P35218 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20967265 | 0.88 | CYP1A2 (0.50) | CYP1A2CYP2A6BACE1CYP1A1ACHE | |
| SCHEMBL8141016 | 0.88 | CYP1A2 (0.50) | CYP1A2CYP2A6BACE1CYP1A1ACHE | |
| SCHEMBL8149328 | 0.84 | CYP1A1 (0.49) | CYP1A2CYP2A6BACE1CYP1A1ABL1 | |
| SCHEMBL8150199 | 0.84 | CYP1A2 (0.46) | CYP1A2CYP2A6BACE1CYP1A1CA3 | |
| SCHEMBL8141581 | 0.84 | CYP1A1 (0.49) | CYP1A2CYP2A6BACE1CYP1A1ABL1 | |
| SCHEMBL8154108 | 0.84 | CYP1A2 (0.46) | CYP1A2CYP2A6BACE1CYP1A1CA3 | |
| SCHEMBL11303205 | 0.83 | CYP1A2 (0.68) | CYP1A2CYP2A6BACE1AHRL3MBTL1 | |
| SCHEMBL3828830 | 0.83 | CYP1A2 (0.68) | CYP1A2CYP2A6BACE1AHRL3MBTL1 | |
| SCHEMBL6562601 | 0.83 | CYP1A2 (0.77) | CYP1A2CYP2A6BACE1AHRL3MBTL1 | |
| SCHEMBL30366405 | 0.83 | CYP1A2 (0.77) | CYP1A2CYP2A6BACE1AHRL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7884249-B2 | oxidizing a diol derivative with an oxidizing agent such as osmium tetraoxide to form 6,13-ethanopentacene-6,13-dione | CANON KABUSHIKI KAISHA (JP) | 2011-02-08 | — | — | US | disclosed |
| US-7884249-B2 | oxidizing a diol derivative with an oxidizing agent such as osmium tetraoxide to form 6,13-ethanopentacene-6,13-dione | CANON KABUSHIKI KAISHA (JP) | 2011-02-08 | — | — | US | disclosed |
| US-20090317753-A1 | BICYCLO COMPOUND, METHOD FOR PRODUCING PENTACENE AND A FILM THEREOF USING THE SAME, AND METHOD FOR PRODUCING BICYCLO COMPOUND | CANON KABUSHIKI KAISHA (JP) | 2009-12-24 | — | — | US | disclosed |
| US-20090317753-A1 | BICYCLO COMPOUND, METHOD FOR PRODUCING PENTACENE AND A FILM THEREOF USING THE SAME, AND METHOD FOR PRODUCING BICYCLO COMPOUND | CANON KABUSHIKI KAISHA (JP) | 2009-12-24 | — | — | US | disclosed |
| US-7601478-B2 | Bicyclo compound, method for producing fused aromatic compound using the same and method for forming film of the same | CANON KABUSHIKI KAISHA (JP) | 2009-10-13 | — | — | US | disclosed |
| US-7601478-B2 | Bicyclo compound, method for producing fused aromatic compound using the same and method for forming film of the same | CANON KABUSHIKI KAISHA (JP) | 2009-10-13 | — | — | US | disclosed |
| US-7588959-B2 | Organic field effect transistor and method for producing the same | CANON KABUSHIKI KAISHA (JP) | 2009-09-15 | — | — | US | disclosed |
| US-7588959-B2 | Organic field effect transistor and method for producing the same | CANON KABUSHIKI KAISHA (JP) | 2009-09-15 | — | — | US | disclosed |
| US-20040116399-A1 | Inhibitors of factor Xa | MILLENNIUM PHARMACEUTICALS, INC. | 2004-06-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090317753-A1 | BICYCLO COMPOUND, METHOD FOR PRODUCING PENTACENE AND A FILM THEREOF USING THE SAME, AND METHOD FOR PRODUCING BICYCLO COMPOUND | C9, C5, RNF168 | CYP1A2 86/4885CYP2A6 1084/4885BACE1 399/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.